Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hideaki Nagase

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequence

Concepts & Ideas

Physiology

Enzyme Activation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
15
Brew, Keith
13
Suzuki, Kazushi
12
Fields, Gregg
10
Lauer-Fields, Janelle
9
Troeberg, Linda
9
Enghild, Jan
8
Bode, Wolfram
8
Itoh, Yoshifumi
8
Visse, Robert
7
Maskos, Klaus
6
Chung, Linda
5
Huang, Wei
5
Itoh, Yoshifumi
5
Seiki, Motoharu
4
Sarras, Michael

Sign-in to see all Coauthors

Publications

TOP 3
Nuti Elisa; Casalini Francesca; Avramova Stanislava I; Santamaria Salvatore; Cercignani Giovanni; Marinelli Luciana; La Pietra Valeria; Novellino Ettore; Orlandini Elisabetta; Nencetti Susanna; Tuccinardi Tiziano; Martinelli Adriano; Lim Ngee-Han; Visse Robert; Nagase Hideaki; Rossello Armando
N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
Miller Mary-Clare; Manning Hugh B; Jain Abhilash; Troeberg Linda; Dudhia Jayesh; Essex David; Sandison Ann; Seiki Motoharu; Nanchahal Jagdeep; Nagase Hideaki; Itoh Yoshifumi
Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
Troeberg Linda; Fushimi Kazunari; Khokha Rama; Emonard Hervé; Ghosh Peter; Nagase Hideaki
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hideaki Nagase (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nuti Elisa; Casalini Francesca; Avramova Stanislava I; Santamaria Salvatore; Cercignani Giovanni; Marinelli Luciana; La Pietra Valeria; Novellino Ettore; Orlandini Elisabetta; Nencetti Susanna; Tuccinardi Tiziano; Martinelli Adriano; Lim Ngee-Han; Visse Robert; Nagase Hideaki; Rossello Armando
N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
Journal of medicinal chemistry 2009;52(15):4757-73.
2009: Miller Mary-Clare; Manning Hugh B; Jain Abhilash; Troeberg Linda; Dudhia Jayesh; Essex David; Sandison Ann; Seiki Motoharu; Nanchahal Jagdeep; Nagase Hideaki; Itoh Yoshifumi
Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
Arthritis and rheumatism 2009;60(3):686-97.
2008: Troeberg Linda; Fushimi Kazunari; Khokha Rama; Emonard Hervé; Ghosh Peter; Nagase Hideaki
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(10):3515-24.
2008: Itoh Yoshifumi; Ito Noriko; Nagase Hideaki; Seiki Motoharu
The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface.
The Journal of biological chemistry 2008;283(19):13053-62.
2008: Fushimi Kazunari; Troeberg Linda; Nakamura Hiroyuki; Lim Ngee Han; Nagase Hideaki
Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.
The Journal of biological chemistry 2008;283(11):6706-16.
2008: Lauer-Fields Janelle L; Spicer Timothy P; Chase Peter S; Cudic Mare; Burstein Gayle D; Nagase Hideaki; Hodder Peter; Fields Gregg B
Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate.
Analytical biochemistry 2008;373(1):43-51.
2008: Jacobsen Jonas; Visse Robert; Sørensen Hans Peter; Enghild Jan J; Brew Keith; Wewer Ulla M; Nagase Hideaki
Catalytic properties of ADAM12 and its domain deletion mutants.
Biochemistry 2008;47(2):537-47.
2008: Nagase Hideaki; Fushimi Kazunari
Elucidating the function of non catalytic domains of collagenases and aggrecanases.
Connective tissue research 2008;49(3):169-74.
2007: Gendron Christi; Kashiwagi Masahide; Lim Ngee Han; Enghild Jan J; Thøgersen Ida B; Hughes Clare; Caterson Bruce; Nagase Hideaki
Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.
The Journal of biological chemistry 2007;282(25):18294-306.
2007: Lauer-Fields Janelle L; Minond Dmitriy; Sritharan Thilaka; Kashiwagi Masahide; Nagase Hideaki; Fields Gregg B
Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases.
The Journal of biological chemistry 2007;282(1):142-50.
2007: Troeberg Linda; Nagase Hideaki
Analysis of TIMP expression and activity.
Methods in molecular medicine 2007;135():251-67.
2006: Minond Dmitriy; Lauer-Fields Janelle L; Cudic Mare; Overall Christopher M; Pei Duanqing; Brew Keith; Visse Robert; Nagase Hideaki; Fields Gregg B
The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
The Journal of biological chemistry 2006;281(50):38302-13.
2006: Itoh Yoshifumi; Ito Noriko; Nagase Hideaki; Evans Richard D; Bird Sarah A; Seiki Motoharu
Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP.
Molecular biology of the cell 2006;17(12):5390-9.
2006: Iyer Shalini; Visse Robert; Nagase Hideaki; Acharya K Ravi
Crystal structure of an active form of human MMP-1.
Journal of molecular biology 2006;362(1):78-88.
2006: Nagase Hideaki; Visse Robert; Murphy Gillian
Structure and function of matrix metalloproteinases and TIMPs.
Cardiovascular research 2006;69(3):562-73.
2005: Wei Shuo; Kashiwagi Masahide; Kota Smitha; Xie Zhihong; Nagase Hideaki; Brew Keith
Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
The Journal of biological chemistry 2005;280(38):32877-82.
2005: Anilkumar Narayanapanicker; Uekita Takamasa; Couchman John R; Nagase Hideaki; Seiki Motoharu; Itoh Yoshifumi
Palmitoylation at Cys574 is essential for MT1-MMP to promote cell migration.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(10):1326-8.
2005: Bai Shan; Thummel Ryan; Godwin Alan R; Nagase Hideaki; Itoh Yoshifumi; Li Li; Evans Richard; McDermott Jeffrey; Seiki Motoharu; Sarras Michael P
Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
Matrix biology : journal of the International Society for Matrix Biology 2005;24(4):247-60.
2005: Jozic Daniela; Bourenkov Gleb; Lim Ngee-Han; Visse Robert; Nagase Hideaki; Bode Wolfram; Maskos Klaus
X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding.
The Journal of biological chemistry 2005;280(10):9578-85.
2004: Lauer-Fields Janelle L; Nagase Hideaki; Fields Gregg B
Development of a solid-phase assay for analysis of matrix metalloproteinase activity.
Journal of biomolecular techniques : JBT 2004;15(4):305-16.
2004: Emonard Hervé; Bellon Georges; Troeberg Linda; Berton Alix; Robinet Arnaud; Henriet Patrick; Marbaix Etienne; Kirkegaard Kirstine; Patthy László; Eeckhout Yves; Nagase Hideaki; Hornebeck William; Courtoy Pierre J
Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism.
The Journal of biological chemistry 2004;279(52):54944-51.
2004: Troeberg Linda; Nagase Hideaki
Monitoring metalloproteinase activity using synthetic fluorogenic substrates.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2004;Chapter 21():Unit 21.16.
2004: Troeberg Linda; Nagase Hideaki
Zymography of metalloproteinases.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2004;Chapter 21():Unit 21.15.
2004: Minond Dmitriy; Lauer-Fields Janelle L; Nagase Hideaki; Fields Gregg B
Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
Biochemistry 2004;43(36):11474-81.
2004: Chung Linda; Dinakarpandian Deendayal; Yoshida Naoto; Lauer-Fields Janelle L; Fields Gregg B; Visse Robert; Nagase Hideaki
Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.
The EMBO journal 2004;23(15):3020-30.
2004: Sultan Sabena; Gosling Martin; Nagase Hideaki; Powell Janet T
Shear stress-induced shedding of soluble intercellular adhesion molecule-1 from saphenous vein endothelium.
FEBS letters 2004;564(1-2):161-5.
2004: Kashiwagi Masahide; Enghild Jan J; Gendron Christi; Hughes Clare; Caterson Bruce; Itoh Yoshifumi; Nagase Hideaki
Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
The Journal of biological chemistry 2004;279(11):10109-19.
2004: Saklatvala Jeremy; Nagase Hideaki
Report on the Molecular Approaches to Osteoarthritis Symposium, Imperial College London, UK, 18-20 April 2004.
Arthritis research & therapy 2004;6(5):203-7.
2003: Gendron Christi; Kashiwagi Masahide; Hughes Clare; Caterson Bruce; Nagase Hideaki
TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors.
FEBS letters 2003;555(3):431-6.
2003: Lauer-Fields Janelle L; Kele Péter; Sui Guodong; Nagase Hideaki; Leblanc Roger M; Fields Gregg B
Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
Analytical biochemistry 2003;321(1):105-15.
2003: Zhang Jinsong; Bai Shan; Zhang Xiaoming; Nagase Hideaki; Sarras Michael P
The expression of gelatinase A (MMP-2) is required for normal development of zebrafish embryos.
Development genes and evolution 2003;213(9):456-63.
2003: Zhang Jinsong; Bai Shan; Tanase Carmen; Nagase Hideaki; Sarras Michael P
The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos.
Development genes and evolution 2003;213(8):382-9.
2003: Zhang Jinsong; Bai Shan; Zhang Xiaoming; Nagase Hideaki; Sarras Michael P
The expression of novel membrane-type matrix metalloproteinase isoforms is required for normal development of zebrafish embryos.
Matrix biology : journal of the International Society for Matrix Biology 2003;22(3):279-93.
2003: Visse Robert; Nagase Hideaki
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
Circulation research 2003;92(8):827-39.
2003: Lauer-Fields Janelle L; Sritharan Thilaka; Stack M Sharon; Nagase Hideaki; Fields Gregg B
Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
The Journal of biological chemistry 2003;278(20):18140-5.
2003: Wei Shuo; Chen Ying; Chung Linda; Nagase Hideaki; Brew Keith
Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
The Journal of biological chemistry 2003;278(11):9831-4.
2003: Nagase Hideaki; Brew Keith
Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
Biochemical Society symposium 2003;(70):201-12.
2003: Troeberg Linda; Nagase Hideaki
Measurement of matrix metalloproteinase activities in the medium of cultured synoviocytes using zymography.
Methods in molecular biology (Clifton, N.J.) 2003;225():77-87.
2003: Nagase Hideaki; Kashiwagi Masahide
Aggrecanases and cartilage matrix degradation.
Arthritis research & therapy 2003;5(2):94-103.
2002: Troeberg Linda; Tanaka Mitsuo; Wait Robin; Shi Yeunian E; Brew Keith; Nagase Hideaki
E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
Biochemistry 2002;41(50):15025-35.
2002: Nagase Hideaki; Brew Keith
Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.
Arthritis research 2002;4 Suppl 3():S51-61.
2001: Nagase H
Metalloproteases.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 21():Unit 21.4.
2001: Lauer-Fields J L; Broder T; Sritharan T; Chung L; Nagase H; Fields G B
Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Biochemistry 2001;40(19):5795-803.
2001: Kashiwagi M; Tortorella M; Nagase H; Brew K
TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
The Journal of biological chemistry 2001;276(16):12501-4.
2001: Shimokawa K; Nagase H
Purification of MMPs and TIMPs.
Methods in molecular biology (Clifton, N.J.) 2001;151():275-304.
2000: Chung L; Shimokawa K; Dinakarpandian D; Grams F; Fields G B; Nagase H
Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity.
The Journal of biological chemistry 2000;275(38):29610-7.
2000: Lauer-Fields J L; Tuzinski K A; Shimokawa K i; Nagase H; Fields G B
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
The Journal of biological chemistry 2000;275(18):13282-90.
2000: Brew K; Dinakarpandian D; Nagase H
Tissue inhibitors of metalloproteinases: evolution, structure and function.
Biochimica et biophysica acta 2000;1477(1-2):267-83.
2000: Ottl J; Gabriel D; Murphy G; Knäuper V; Tominaga Y; Nagase H; Kröger M; Tschesche H; Bode W; Moroder L
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.
Chemistry & biology 2000;7(2):119-32.
1999: Nagase H; Woessner J F
Matrix metalloproteinases.
The Journal of biological chemistry 1999;274(31):21491-4.
1999: Bode W; Fernandez-Catalan C; Grams F; Gomis-Rüth F X; Nagase H; Tschesche H; Maskos K
Insights into MMP-TIMP interactions.
Annals of the New York Academy of Sciences 1999;878():73-91.
1999: Nagase H; Meng Q; Malinovskii V; Huang W; Chung L; Bode W; Maskos K; Brew K
Engineering of selective TIMPs.
Annals of the New York Academy of Sciences 1999;878():1-11.
1999: Bode W; Fernandez-Catalan C; Tschesche H; Grams F; Nagase H; Maskos K
Structural properties of matrix metalloproteinases.
Cellular and molecular life sciences : CMLS 1999;55(4):639-52.
1999: Meng Q; Malinovskii V; Huang W; Hu Y; Chung L; Nagase H; Bode W; Maskos K; Brew K
Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.
The Journal of biological chemistry 1999;274(15):10184-9.
1999: Bode W; Fernandez-Catalan C; Nagase H; Maskos K
Endoproteinase-protein inhibitor interactions.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1999;107(1):3-10.
1998: Nagase H
Cell surface activation of progelatinase A (proMMP-2) and cell migration.
Cell research 1998;8(3):179-86.
1998: Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
The Journal of biological chemistry 1998;273(38):24360-7.
1998: Suzuki K; Kan C C; Hung W; Gehring M R; Brew K; Nagase H
Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli: autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1).
Biological chemistry 1998;379(2):185-91.
1997: Müller J C; von Roedern E G; Grams F; Nagase H; Moroder L
Non-peptidic cysteine derivatives as inhibitors of matrix metalloproteinases.
Biological chemistry 1997;378(12):1475-80.
1997: Mott J D; Khalifah R G; Nagase H; Shield C F; Hudson J K; Hudson B G
Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility.
Kidney international 1997;52(5):1302-12.
1997: Gomis-Rüth F X; Maskos K; Betz M; Bergner A; Huber R; Suzuki K; Yoshida N; Nagase H; Brew K; Bourenkov G P; Bartunik H; Bode W
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Nature 1997;389(6646):77-81.
1997: Huang W; Meng Q; Suzuki K; Nagase H; Brew K
Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
The Journal of biological chemistry 1997;272(35):22086-91.
1997: Nagase H; Suzuki K; Cawston T E; Brew K
Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1).
The Biochemical journal 1997;325 ( Pt 1)():163-7.
1997: Nagase H
Activation mechanisms of matrix metalloproteinases.
Biological chemistry 1997;378(3-4):151-60.
1997: Korzus E; Nagase H; Rydell R; Travis J
The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression.
The Journal of biological chemistry 1997;272(2):1188-96.
1997: Das S K; Yano S; Wang J; Edwards D R; Nagase H; Dey S K
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.
Developmental genetics 1997;21(1):44-54.
1996: Rankin C A; Suzuki K; Itoh Y; Ziemer D M; Grantham J J; Calvet J P; Nagase H
Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
Kidney international 1996;50(3):835-44.
1996: Benbow U; Butticè G; Nagase H; Kurkinen M
Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
The Journal of biological chemistry 1996;271(18):10715-22.
1996: Huang W; Suzuki K; Nagase H; Arumugam S; Van Doren S R; Brew K
Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield in E. coli.
FEBS letters 1996;384(2):155-61.
1996: Nagase H; Suzuki K; Itoh Y; Kan C C; Gehring M R; Huang W; Brew K
Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation.
Advances in experimental medicine and biology 1996;389():23-31.
1995: Ogata Y; Itoh Y; Nagase H
Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
The Journal of biological chemistry 1995;270(31):18506-11.
1995: Itoh Y; Nagase H
Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
The Journal of biological chemistry 1995;270(28):16518-21.
1995: Itoh Y; Binner S; Nagase H
Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
The Biochemical journal 1995;308 ( Pt 2)():645-51.
1995: Nagase H
Human stromelysins 1 and 2.
Methods in enzymology 1995;248():449-70.
1994: Nagase H; Itoh Y; Binner S
Interaction of alpha 2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms.
Annals of the New York Academy of Sciences 1994;732():294-302.
1994: Nagase H; Fields C G; Fields G B
Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
The Journal of biological chemistry 1994;269(33):20952-7.
1994: Nagase H
Matrix metalloproteinases. A mini-review.
Contributions to nephrology 1994;107():85-93.
1993: Chen L C; Noelken M E; Nagase H
Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1).
Biochemistry 1993;32(39):10289-95.
1992: Ogata Y; Pratta M A; Nagase H; Arner E C
Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator.
Experimental cell research 1992;201(2):245-9.
1992: Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
The Biochemical journal 1992;285 ( Pt 2)():603-11.
1992: Ogata Y; Enghild J J; Nagase H
Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.
The Journal of biological chemistry 1992;267(6):3581-4.
1992: Morodomi T; Suzuki K; Sasaguri Y; Morimatsu M; Nagase H
Comparative studies of a 92-kDa gelatinolytic metalloproteinase from U937 cells and matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts.
Matrix (Stuttgart, Germany). Supplement 1992;1():87-8.
1992: Nagase H; Barrett A J; Woessner J F
Nomenclature and glossary of the matrix metalloproteinases.
Matrix (Stuttgart, Germany). Supplement 1992;1():421-4.
1992: Nagase H; Suzuki K; Morodomi T; Enghild J J; Salvesen G
Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
Matrix (Stuttgart, Germany). Supplement 1992;1():237-44.
1991: Nagase H; Suzuki K; Enghild J J; Salvesen G
Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin).
Biomedica biochimica acta 1991;50(4-6):749-54.
1990: Suzuki K; Enghild J J; Morodomi T; Salvesen G; Nagase H
Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).
Biochemistry 1990;29(44):10261-70.
1990: Nagase H; Enghild J J; Suzuki K; Salvesen G
Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.
Biochemistry 1990;29(24):5783-9.
1990: Suzuki K; Nagase H; Ito A; Enghild J J; Salvesen G
The role of matrix metalloproteinase 3 in the stepwise activation of human rheumatoid synovial procollagenase.
Biological chemistry Hoppe-Seyler 1990;371 Suppl():305-10.
1988: Bejarano P A; Noelken M E; Suzuki K; Hudson B G; Nagase H
Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin).
The Biochemical journal 1988;256(2):413-9.
1988: Ito A; Nagase H
Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase.
Archives of biochemistry and biophysics 1988;267(1):211-6.
1987: Nagase H; Brew K
Amino acid sequence of a 32-residue region around the thiol ester site in duck ovostatin.
FEBS letters 1987;222(1):83-8.

Sign-in to see more